Skip to main content

Table 1 Demographics and clinical data

From: Basal cell adenoma and basal cell adenocarcinoma of the parotid gland: clinical findings and surgical outcomes in a single-institution study

 

Basal cell adenoma

(n = 81)

Basal cell adenocarcinoma (n = 7)

p-value

Mean age (youngest-eldest)

55.1 (23–85)

68.6 (52–87)

0.056

Gender

34 male (42%) 47 female (58%)

7 female (100%)

0.076

Location

81 parotid (100%) 42 left (52%) 39 right (48%)

7 parotid (100%) 3 left (43%) 4 right (57%)

0.193

Preoperative symptoms

61 painless swelling (76.3%) 20 incidental finding (24.7%)

7 painless swelling (100%)

–

Type of parotidectomy

44 partial (54%) 35 superficial (43%) 2 total (2%)

4 partial (57%) 2 superficial (29%) 1 total (14%)

–

Radiologic size of radiologic largest dimension length (smallest-largest) (SD)

2.2 cm (0.5–17) (1.9)

2.4 cm (1.7–3.5) (0.6)

0.16

Pathologic size of tumor (smallest-largest) (SD)

2.1 cm (0.5–12.5) (1.4)

2.9 cm (2.3–3.6) (0.5)

0.011

Median time from detection to operation (shortest-longest)

35.3 months (2-241) Unknown 12 patients

28.8 months (2-121) Unknown 1 patient

0.219

Median follow up (shortest-longest)

39.1 months (1-221)*

36 months (4-121)**

0.678

Postoperative complications

3 hematoma (3.7%) 2 sialocele (2.5%) 1 partial facial nerve palsy (1.2%)

1 facial nerve palsy (14.3%)

0.081

Adjuvant treatment

None

1 chemotherapy (14.3%)

–

Relapse

None***

None****

–

  1. SD Standard Deviation
  2. * 40 patients (49%) had follow up period under 6 months
  3. ** 2 patients (28.6%) received radiotherapy, and 1 patient had lymph node metastasis (pT2N1M0)
  4. *** 1 patient has received second surgery due to recurred basal cell adenoma 14 years ago at other hospital
  5. **** 1 patient expired by cardiac arrest and 1 patient was still alive, but both had no cancer recurrence
  6. 2 patients were lost to follow up